Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study. Sorial MN, Han JX, Koh MJ, Boussi L, et al. Br J Haematol 2025;206:1664-1677.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sorial MN, Han JX, Koh MJ, Boussi L, et al. Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study. Br J Haematol 2025;206:1664-1677.
PMID: 40310502